Latest filing published 16 Apr 2023 for Newbury Pharmaceuticals AB, €8,520.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -39.7%Entry SEK 5.80 · Close at T+365 SEK 3.50
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Anil Okay: trading record in brief
Anil Okay appears in our data through filings on Newbury Pharmaceuticals AB shares, published by Finansinspektionen. We count 2 filings; the first trade dates from 16 August 2022 and the latest from 14 April 2023.
Every open-market trade on record is a purchase: 1 purchase worth €8,520, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2023, the count stands at 1 purchase and no sales.
The record was last updated on 16 April 2023 with an open-market purchase (€8,520) in Newbury Pharmaceuticals AB. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Companies and markets linked to Anil Okay
Open company profiles for insider transactions, fundamentals and analyst consensus when available.